Genetic engineering of T-cell receptors: TCR takes to titin

Abstract

In this issue of Blood, Linette et al report a cautionary tale - a lethal off-target toxicity following T-cell receptor (TCR) optimization to enhance affinity against a tumor-associated antigen, MAGE-A3. © 2013 by The American Society of Hematology.